If the treatment is available as a result of the accelerated approval nobody is going to opt for a placebo controlled trial and risk dying. It has to be a single arm trial with a control to an historic data control.
- Forums
- ASX - By Stock
- MSB
- Ann: Mesoblast Maintains Momentum with FDA
MSB
mesoblast limited
Add to My Watchlist
1.34%
!
$1.84

Ann: Mesoblast Maintains Momentum with FDA, page-38
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.84 |
Change
-0.025(1.34%) |
Mkt cap ! $2.335B |
Open | High | Low | Value | Volume |
$1.88 | $1.94 | $1.82 | $10.39M | 5.576M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
31 | 147726 | $1.83 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.84 | 134 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
30 | 147705 | 1.830 |
12 | 21960 | 1.825 |
10 | 40938 | 1.820 |
13 | 132632 | 1.815 |
11 | 59557 | 1.810 |
Price($) | Vol. | No. |
---|---|---|
1.835 | 13637 | 12 |
1.840 | 33783 | 11 |
1.845 | 115462 | 11 |
1.850 | 41602 | 11 |
1.855 | 40298 | 8 |
Last trade - 15.56pm 17/06/2025 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
RC1
REDCASTLE RESOURCES LIMITED
Ronald Miller, Non-Executive Director
Ronald Miller
Non-Executive Director
SPONSORED BY The Market Online